Momenta Phamaceuticals, Inc. (MNTA) Posts Surprise Q1 Loss
Tweet
Share
E-mailGet Alerts MNTA Hot Sheet
Price: $52.48 --0%
Financial Fact:
Total collaboration revenue: 29.14M
Today's EPS Names:
BVFL, MCET, REOS, More
Financial Fact:
Total collaboration revenue: 29.14M
Today's EPS Names:
BVFL, MCET, REOS, More
Join SI Premium – FREE
Momenta Phamaceuticals, Inc. (NASDAQ: MNTA) reported Q1 EPS of ($0.10), $0.31 worse than the analyst estimate of $0.21. Revenue for the quarter came in at $24.2 million versus the consensus estimate of $37.38 million.
For earnings history and earnings-related data on Momenta Phamaceuticals, Inc. (MNTA) click here.
For earnings history and earnings-related data on Momenta Phamaceuticals, Inc. (MNTA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SAP Q1 results fall short of Wall Street estimates as transformation kicks off
- Ameriprise Financial's quarterly profit rises on higher fees, AUM
- Equity Lifestyle Properities (ELS) Tops Q1 EPS by 11c, provides guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
